CYCLOPHARM LIMITED — Director's Dealing 2012

Nov 5, 2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CYCLOPHARM LIMITED ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	James McBrayer
Date of last notice	26/5/2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Carolyn Reid McBrayer (wife)
Date of change	4/06/2012
No. of securities held prior to change	300,000
Class	Ordinary Shares
Number acquired	Nil
Number disposed	240,000
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation	Not applicable
No. of securities held after change	60,000

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

	Nature of	change			Reduction	arising f	rom share
	Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back				consolidation

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Nil
Nature of interest	Nil
Name of registered holder	Nil
(if issued securities)
Date of change	Nil
No. and class of securities to which	Nil
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	Nil
Interest disposed	Nil
Value/Consideration	Nil
Note: If consideration is non‐cash, provide details
and an estimated valuation
Interest after change	Nil

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed	Nil
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade	Nil
to proceed during this period?
If prior written clearance was provided, on what date was this	Nil
provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011